LI
RMD icon

LVZ Inc’s ResMed RMD Stock Holding History

LVZ Inc’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,145
Closed -$250K – 144
2023
Q2 		$250K Hold
1,145
– – 0.03% 123
2023
Q1 		$251K Sell
1,145
-460
-29% -$99.8K 0.04% 119
2022
Q4 		$334K Buy
+1,605
New +$353K 0.05% 93

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

LVZ Inc's RMD Position: Q3 2023 in Review

LVZ Inc sold out of ResMed (RMD) in Q3 2023, closing a stake of 1,145 shares — an estimated $250K sold.

LVZ Inc first reported a position in RMD in Q4 2022 and held it in 3 quarters. The position peaked at $334K in Q4 2022. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • LVZ Inc reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • LVZ Inc sold 1,145 ResMed shares in Q3 2023, an estimated $250K.
  • LVZ Inc first reported a position in ResMed in Q4 2022 and held it in 3 quarters.
  • LVZ Inc's ResMed position peaked at $334K in Q4 2022.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on LVZ Inc's 13F filing for Q3 2023, filed 8 Nov 2023.